...
首页> 外文期刊>Asian journal of surgery >Laparoscopic adrenalectomy --- is it any different in phaeochromocytoma and non-phaeochromocytoma?
【24h】

Laparoscopic adrenalectomy --- is it any different in phaeochromocytoma and non-phaeochromocytoma?

机译:腹腔镜肾上腺切除术---嗜铬细胞瘤和非嗜铬细胞瘤有什么不同吗?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Laparoscopic adrenalectomy (LA) for phaeochromocytoma is a feasible, safe and effective treatment. The effects of associated catecholamine release render LA more challenging, although with comparable morbidity to LA for other diseases of the adrenal gland. METHODS: Data from case records of 44 patients who underwent LAs between May 2002 and May 2006 were analysed retrospectively. The patients were divided into a phaeochromocytoma group (Group I) and a non-phaeochromocytoma group (Group II). The aim of this study was to assess the operative course and outcome of LA in the two groups. RESULTS: The mean operating time and blood loss were slightly higher in LA for phaeochromocytomas compared to LA for other pathologies, but these differences were not statistically significant. The mean hospital stay was 3.84 days in both groups. The phaeochromocytoma group had a slightly higher complication rate of 21% compared to 12%. None of the procedures needed open conversion. A terminal hand assist was employed in two patients in Group I and one patient in Group II. Two patients with bilateral phaeochromocytoma had single stage bilateral LA. CONCLUSION: LA is feasible and effective in phaeochromocytoma. It is associated with a slightly longer operating time, more blood loss and complications when compared with non-phaeochromocytoma masses. LA can be done in a single operation for bilateral masses. Terminal hand assist is a viable and effective option for very large masses.
机译:背景:腹腔镜肾上腺切除术(LA)用于嗜铬细胞瘤是一种可行,安全和有效的治疗方法。儿茶酚胺释放的相关作用使LA更具挑战性,尽管与其他肾上腺疾病的发病率相当。方法:回顾性分析2002年5月至2006年5月期间发生LA的44例患者的病例记录。将患者分为嗜铬细胞瘤组(I组)和非嗜铬细胞瘤组(II组)。本研究的目的是评估两组LA的手术过程和结果。结果:与其他病变相比,嗜铬细胞瘤的平均手术时间和失血量略多于洛杉矶,但这些差异在统计学上没有统计学意义。两组的平均住院天数为3.84天。嗜铬细胞瘤组的并发症发生率从12%升高到21%。这些程序都不需要公开转换。在第一组的两名患者和第二组的一名患者中采用了末端助行器。两名双侧嗜铬细胞瘤的患者患有单期双侧LA。结论:LA在嗜铬细胞瘤中是可行和有效的。与非嗜铬细胞瘤肿块相比,它与手术时间稍长,失血更多和并发症相关。对于双边群众,洛杉矶可以一次完成手术。终端助手是非常大质量的一种可行且有效的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号